GIAVANNA SAMMARONE: Open Payments
NPI 1801671664 · HUBBARD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,572 in 220 payments from 20 companies in 2025. Trend: 2023 $517 · 2024 $3,077 · 2025 $3,572
Food & beverage: $3,572
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 74 | $1,132 |
| AstraZeneca Pharmaceuticals LP | 19 | $743 |
| Bayer Healthcare Pharmaceuticals Inc. | 19 | $275 |
| PFIZER INC. | 28 | $266 |
| Lilly USA, LLC | 15 | $211 |
| Novo Nordisk Inc | 14 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $176 |
| Amgen Inc. | 17 | $153 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| SHIELD THERAPEUTICS INC | 3 | $52 |
Products named: QULIPTA, BREZTRI, UBRELVY, VRAYLAR, AIRSUPRA, Kerendia, JARDIANCE, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
